市場調查報告書
商品編碼
1287293
心電圖壓力測試市場 - 按產品類型(運動測試系統、壓力血壓計、壓力心電圖、脈搏血氧儀),按最終用途(醫院、診斷中心、非住院手術中心),及預測,2023 - 2032年ECG Stress Test Market - By Product Type (Exercise Testing Systems, Stress Blood Pressure Monitors, Stress ECG, Pulse Oximeters), By End-use (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), & Forecast, 2023 - 2032 |
到2032年,全球心電圖壓力測試市場規模將大幅擴大。老年人口的成長和老齡人對心血管疾病(如中風、心臟驟停等)的高敏感度,增加了對心電圖壓力測試的需求。根據世界衛生組織的數據,到2030年,全球每6個人中就有1個是60歲及以上的人。
該領域的行業競爭者正在強調合併和收購戰略,以擴大其足跡。例如,2022年7月,美國跨國醫療技術公司Becton Dickinson and Co.完成了對Parata Systems的收購,後者是藥房自動化組合領域的領導者。這次收購將幫助該公司提供智慧和互聯護理技術。
整個心電圖壓力測試市場根據產品、終端用途和地區加以分類。
就產品而言,應激式血壓計的市場價值將在2032年之前積累大量收益。這些監測器的高精確度增加了它們的採用。此外,全球心血管疾病發病率的上升進一步增加了對這些監測器的需求。根據CDC的數據,僅在美國,每年就有超過79.5萬人被診斷出中風。應激式血壓計已經經歷了幾次升級,現在擁有先進的功能。
對於患有高血壓或其他心血管疾病的人來說,壓力血壓計有助於評估藥物治療或生活方式干預的有效性。它有助於確定是否存在高血壓、低血壓或不規則血壓波動等情況。
就終端用途而言,非住院手術中心部分的心電圖壓力測試市場規模到2032年將明顯擴大。這些設施對心血管疾病的高成本效益的治療方案的可用性,促進了該部分的擴張。這些設施是為門診手術設計的,這意味著它們可以提供比醫院更快和更有效的服務。它們還配備了最先進的工具來進行準確的疾病診斷。
在區域方面,從2023年到2032年,亞太地區心電圖壓力測試的市場佔有率將以顯著的複合年成長率成長。心血管疾病的高發病率增加了該地區對心電圖壓力測試的需求。此外,隨著人口迅速老齡化,政府對醫療保健部門的有利支持,也進一步積極影響了該地區的前景。幾個區域經濟體的政府也在對醫療設備部門進行大量投資,這可能有助於為該區域的行業開闢一條健康的成長軌跡。
Global ECG Stress Test Market size will expand substantially through 2032. Growing geriatric population and the higher susceptibility of aging people to cardiovascular diseases such as stroke, cardiac arrest, and others have increased the need for ECG stress tests. As per the WHO, 1 in every 6 people across the globe will be 60 years and above by 2030.
Industry contenders in this field are emphasizing mergers and acquisition strategies to extend their footprint. For instance, in July 2022, Becton Dickinson and Co., an American multinational medical technology company, completed the acquisition of Parata Systems, a leader in the pharmacy automation portfolio space. This acquisition will help the company deliver smart and connected care technologies.
The overall ECG stress test market is classified based on product, end-use, and region.
In terms of product, stress blood pressure monitors market value will amass substantial gains through 2032. High accuracy of these monitors has increased their adoption. Moreover, the rising prevalence of cardiovascular disorders globally has further increased the need for these monitors. As per the CDC, stroke is diagnosed in over 795,000 people every year in the U.S. alone. Stress blood pressure monitors have undergone several upgrades and now boast advanced features.
For individuals with hypertension or other cardiovascular conditions, stress blood pressure monitors help evaluate the effectiveness of medication or lifestyle interventions. It helps determine the presence of conditions such as hypertension, hypotension, or irregular blood pressure fluctuations.
With respect to end-use, the ECG stress test market size from the ambulatory surgical centers segment will expand notably through 2032. High availability of cost-effective treatment solutions in these facilities for cardiovascular disorders is contributing to segment expansion. These facilities are designed for outpatient procedures, implying they can provide faster and more efficient services than hospitals. They are also equipped with cutting-edge tools for accurate disease diagnosis.
On the regional front, the Asia Pacific ECG stress test market share will grow at a significant CAGR from 2023 to 2032. High incidence rate of cardiovascular disorders has increased the demand for ECG stress tests in the region. Moreover, favorable government support towards the healthcare sector, in line with a rapidly aging population, is further positively affecting the regional outlook. Governments across several regional economies are also investing significantly in the medical device sector, which may help carve a healthy growth trajectory for the regional industry.